Hikma Pharmaceuticals: an Emerging Markets Multinational By : Radi Haloub and John Anchor Industry Background The emergence of the pharmaceutical industry, in the late 1850s, was a breakthrough during which drug makers created the slogan “You Have a Problem, We Have a Pill” (Lynn, 1993: 5). This slogan reflected that fact that the pharmaceutical business was one of the world's largest industries, in addition to being one of the most profitable ones. Since that time, developments in medicine have
Words: 4085 - Pages: 17
firms were left under the state control and continued operating at a break-even level. Second, a rapid growth of the pharmaceutical industry in Russia and its availability for the imports from western and eastern companies intensified competition among many producers. Today, an increasing amount of pharmacies is the main reason of increased competition in the Russian pharmaceutical industry. Moreover, an assortment of products has expanded. In 1990s, the new non-traditional types of products became
Words: 2351 - Pages: 10
Part 1- Framing the Project Portfolio Management Problem 1. What are the objectives? The objective is to research and develop pharmaceuticals products based on the selections that minimize cost and maximize value and sales. There will be a discussion of which projects will be allocated additional resources and at what cost. 2. What are the constraints? Competition is usually between brand-name drugs. Constraints for the study include risky drug discovery and development which could cause harm
Words: 296 - Pages: 2
Generic Prescription Drug Costs Prescription drugs have been causing problems in the United States for a very long time. Pharmaceutical companies are one of the largest profiting global industries. It was in 2009 when drug shortages increased with numbers reaching what many have termed crisis level which raised all prices of generic prescription drugs significantly (Fox, Sweet, & Jensen, 2014). This increase was and still is leaving patients with a life threatening decision; either go on
Words: 3188 - Pages: 13
much to make a drug, both money and time wise, but at the same time this drugs are developed for people, to say alive. While some health activist, companies and government agencies are fighting so hard to make drugs accessible and affordable, pharmaceutical companies are also fighting to maximize profit as much as possible. Profit and utility maximization is an ethical issue, as well as it is an economic issue. If there is no balance between these two factors, there will definitely be a great
Words: 375 - Pages: 2
Risks 1. Discovery a. Extend data exclusivity period for areas of unmet need. b. Extend exclusivity period for small-molecule therapies. c. Sync the data exclusivity period for drugs approved under section 505(b) of the FDCA and biologicals approved under section 351 of the PHSA. d. Provide market exclusivity – independent of patent life – for compounds that attenuate Alzheimer’s pathology and slow dementia progression. 2. Discovery/Development e. "HR 3116:
Words: 1062 - Pages: 5
biosimilars was established in the European Union in 2003 and European Medicines Agency (EMA) has already approved 19 biosimilars. The healthcare costs were reduced in the US due to the availability of generic chemical drugs. According to the generic pharmaceutical association’s report, “Over the period of 2003 through 2012,
Words: 1491 - Pages: 6
follow, and we’ll e-mail you free updates as they’re published. You’ll receive free e-mail news updates each time a new story is published. You’re all set! Sign up Steven Nissen, a heart specialist at The Cleveland Clinic, has linked pharmaceutical drugs such as Vioxx and Avandia with high cardiovascular risks in patients. (Dustin Franz/FOR THE WASHINGTON POST) By Peter Whoriskey November 24, 2012 For drugmaker GlaxoSmithKline, the 17-page article in the New England Journal of Medicine
Words: 4274 - Pages: 18
Case Study: GlaxoSmithKline, Bristol-Myers Squibb, and AIDS in Africa In this case study analysis paper, I shall argue that it is morally acceptable for Indian drug companies to copy and sell the AIDS drugs developed by GlaxoSmithKline and Bristol-Myers Squibb. The reasons and evidence that support this moral judgment are as follows: Utilitarianism states that an action is morally correct if the sum total benefits produced by the action is greater than the sum total of benefits produced by any
Words: 2991 - Pages: 12
Sandra Mote Microeconomics April 25, 2015 The Merge between Watson Pharmaceutical and Arrow When two firms or companies reach an agreement to combine together is called merge. When one company buys out another company is called an acquisition. There are a variety reasons for either of the two and both are a concern to the public and to policy makers. Mergers are known to have an impact on market concentration and on the welfare of the public. Mergers
Words: 638 - Pages: 3
